Last reviewed · How we verify

NCT07301398

Development & Preliminary Validation of a Community Health Education Program

Not yet recruiting Last updated 24 December 2025
What this trial tests

trial testing The use and guidance of the mini-program in Non-neoplastic and Non-infectious Diseases in 92 participants. Not yet recruiting.

Timeline
30 December 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment92
Start date30 December 2025
Primary completion31 December 2026
Estimated completion31 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Who can join

18 and older, any sex, with Non-neoplastic and Non-infectious Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study analyzes the needs of patients regarding the content and form of home-based health education through interviews, and constructs a health education program tailored to these needs. A practical WeChat mini-program is developed to enable patients with interstitial lung disease to promptly access comprehensive health education information, consult about follow-up visits, and check test reports during their home care period, ultimately aiming to improve patients' quality of life and reduce medical consumption.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07301398.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing